公司概覽
業務類別 --
業務概覽 Actinogen Medical Ltd is a biotechnology company. The company develops a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated cortisol in the brain. It is focused on the clinical development of Xanamem,an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.
公司地址 109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
電話號碼 +61 289647401
傳真號碼 +61 289647588
公司網頁 https://www.actinogen.com.au
員工數量 --
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
沒有相關資料。
 
董事會成員
董事會 職務 更新日期
沒有相關資料。
 
所屬ETF (更新日期: 07/03/2026 03:48)
代號 名稱 佔比% 持有日期
SPDWState Street® SPDR® Ptf Dev Wld exUS ETF<0.000001%27/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.